Search research articles
Contact Us
Filters
Showing results (21-30 of 70) with videos related to
Page
of 7
Sort By:
European Journal of Haematology
|
August 14, 2025
Renal Involvement in Chronic Graft-Versus-Host Disease
Nihar Desai, Arjun Datt Law, Christianne Bourlon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 17, 2018
Reduced-Intensity Conditioning and Dual T Lymphocyte Suppression with Antithymocyte Globulin and Post-Transplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplants for Hematological Malignancies
Arjun Datt Law, Maria Queralt Salas, Wilson Lam, et al.
Annals of Hematology
|
March 12, 2021
Moderate-severe grade of chronic graft versus host disease and younger age (less than 45 years old) are risk factors for avascular necrosis in adult patients undergoing allogeneic hematopoietic cell transplantation
Arjun Datt Law, Sita Bhella, Ivan Pasic, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 7, 2019
Combination of the Centre for International Blood and Marrow Transplant Registry Risk Score and the Global Severity Score Enhances Prognostic Risk Stratification in Patients Receiving Frontline Therapy for Chronic Graft-versus-Host Disease
Roman M Shapiro, Elizabeth Shin, Arjun Datt Law, et al.
European Journal of Haematology
|
September 13, 2019
Reduced-intensity conditioning allogeneic transplant with dual T-cell depletion in myelofibrosis
Maria Queralt Salas, Wilson Lam, Arjun Datt Law, et al.
Annals of Hematology
|
December 21, 2022
The association between nutritional risk index and ICU outcomes across hematologic malignancy patients with acute respiratory failure
Riddhi Kundu, Rena Seeger, Michael D Elfassy, et al.
European Journal of Haematology
|
January 31, 2022
Allogeneic hematopoietic stem cell transplantation in patients with therapy-related hematologic malignancies developing after multiple myeloma
Ram Vasudevan Nampoothiri, Ivan Pasic, Arjun Datt Law, et al.
Clinical Hematology International
|
October 1, 2021
Safety and Efficacy of Haploidentical Peripheral Blood Stem Cell Transplantation for Myeloid Malignancies Using Post-transplantation Cyclophosphamide and Anti-thymocyte Globulin as Graft-<i>versus</i>-Host Disease Prophylaxis
Maria Queralt Salas, Arjun Datt Law, Wilson Lam, et al.
British Journal of Haematology
|
September 18, 2025
Can we move beyond myeloablative conditioning (MAC)? A comparison of MAC versus reduced intensity conditioning (RIC) in patients aged younger than 65 years undergoing allogeneic haematopoietic cell transplantation using ATG-PTCy-CSA for GVHD prophylaxis
Ruah Alyamany, Ahmed Alnughmush, Mats Remberger, et al.
European Journal of Haematology
|
March 3, 2020
Outcomes of therapy-related acute lymphoblastic leukemia in adults after allogeneic stem cell transplantation
Ram Vasudevan Nampoothiri, Arjun Datt Law, Wilson Lam, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 70) with videos related to
Sort By:
Page
of 7
European Journal of Haematology
|
August 14, 2025
Renal Involvement in Chronic Graft-Versus-Host Disease
Nihar Desai, Arjun Datt Law, Christianne Bourlon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 17, 2018
Reduced-Intensity Conditioning and Dual T Lymphocyte Suppression with Antithymocyte Globulin and Post-Transplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplants for Hematological Malignancies
Arjun Datt Law, Maria Queralt Salas, Wilson Lam, et al.
Annals of Hematology
|
March 12, 2021
Moderate-severe grade of chronic graft versus host disease and younger age (less than 45 years old) are risk factors for avascular necrosis in adult patients undergoing allogeneic hematopoietic cell transplantation
Arjun Datt Law, Sita Bhella, Ivan Pasic, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 7, 2019
Combination of the Centre for International Blood and Marrow Transplant Registry Risk Score and the Global Severity Score Enhances Prognostic Risk Stratification in Patients Receiving Frontline Therapy for Chronic Graft-versus-Host Disease
Roman M Shapiro, Elizabeth Shin, Arjun Datt Law, et al.
European Journal of Haematology
|
September 13, 2019
Reduced-intensity conditioning allogeneic transplant with dual T-cell depletion in myelofibrosis
Maria Queralt Salas, Wilson Lam, Arjun Datt Law, et al.
Annals of Hematology
|
December 21, 2022
The association between nutritional risk index and ICU outcomes across hematologic malignancy patients with acute respiratory failure
Riddhi Kundu, Rena Seeger, Michael D Elfassy, et al.
European Journal of Haematology
|
January 31, 2022
Allogeneic hematopoietic stem cell transplantation in patients with therapy-related hematologic malignancies developing after multiple myeloma
Ram Vasudevan Nampoothiri, Ivan Pasic, Arjun Datt Law, et al.
Clinical Hematology International
|
October 1, 2021
Safety and Efficacy of Haploidentical Peripheral Blood Stem Cell Transplantation for Myeloid Malignancies Using Post-transplantation Cyclophosphamide and Anti-thymocyte Globulin as Graft-<i>versus</i>-Host Disease Prophylaxis
Maria Queralt Salas, Arjun Datt Law, Wilson Lam, et al.
British Journal of Haematology
|
September 18, 2025
Can we move beyond myeloablative conditioning (MAC)? A comparison of MAC versus reduced intensity conditioning (RIC) in patients aged younger than 65 years undergoing allogeneic haematopoietic cell transplantation using ATG-PTCy-CSA for GVHD prophylaxis
Ruah Alyamany, Ahmed Alnughmush, Mats Remberger, et al.
European Journal of Haematology
|
March 3, 2020
Outcomes of therapy-related acute lymphoblastic leukemia in adults after allogeneic stem cell transplantation
Ram Vasudevan Nampoothiri, Arjun Datt Law, Wilson Lam, et al.
Page
of 7